Niferex® Once-Daily Iron Supplement | Gentle & Effective Iron Support

One tablet, once-daily, gluten-free, lactose-free, sugar-free¹
Sumalate^® (ferrous asparto glycinate) is a highly bioavailable form of iron^1-4
Two iron absorption promoters: Vitamin C (ascorbic acid) and Succinic acid^5-9
The proprietary iron form of Sumalate^® in Niferex^® may lead to less GI upset^2,10
May be taken with or without food^11*

Iron (as Sumalate^®) ferrous asparto glycinate
75 mg
Highly bioavailable, chelated iron for increased absorption^1-4

Vitamin C
175 mg
Facilitates iron entry into the enterocytes^5,6,9

Succinic Acid
150 mg
Helps transport iron from enterocytes into the bloodstream^7-9

Folate (as 1.4 mg Quatrefolic^®)
1700 mcg DFE
Bioactive folate to help ensure optimal plasma folate status to help prevent iron deficiency^12,13

Vitamin B12
25 mcg
Supports healthy red blood cell maturation¹⁴

Zinc
15 mg
Supports a healthy immune system, supports cell division and growth¹⁵

Iron (as Sumalate^®) ferrous asparto glycinate Highly bioavailable, chelated iron for increased absorption^1-4
75 mg

Vitamin C Facilitates iron entry into the enterocytes^5,6,9
175 mg

Succinic Acid Helps transport iron from enterocytes into the bloodstream^7-9
150 mg

Folate (as 1.4 mg Quatrefolic^®) Bioactive folate to help ensure optimal plasma folate status to help prevent iron deficiency^12,13
1700 mcg DFE

Vitamin B12 Supports healthy red blood cell maturation¹⁴
25 mcg

Zinc Supports a healthy immune system, supports cell division and growth¹⁵
15 mg

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.

Please click below to view full Prescribing Information, including Boxed Warning.

Prescribing Information

Two Ways to Save on Niferex^® 30-Count Bottles

At the Pharmacy

Present this Niferex^® Savings Card to your pharmacist (along with your prescription if your doctor did not ePrescribe). Tell your pharmacist you want to receive Niferex^® for every prescription fill. When you pick up your prescription, ensure that you received Niferex^® and that the Savings Card was applied.

Download Savings Card

Direct-to-Patient Pharmacy

Pay as little as $45 cash for a 30-day supply or $120 cash for a 90-day supply

Get Niferex® consistently and conveniently with free home delivery by asking your provider to send your prescription to Glendale Pharmacy. Glendale Pharmacy offers free standard shipping on all prescriptions to select states. Click here to confirm if Glendale delivers to your state.

Glendale Pharmacy also accepts health insurance in select states, which may reduce your out-of-pocket cost even further. Click here to confirm if Glendale accepts insurance in your state. Terms and conditions may apply.

Learn More

For Healthcare Professionals

Interested in prescribing Niferex^® in your practice?
Request samples today!

Request Samples

Niferex^® Savings Card Terms & Conditions

By using the Niferex® Savings Offer, you acknowledge that you currently meet the eligibility criteria and will comply with the following terms and conditions:

The Card is not valid for prescriptions that are eligible to be reimbursed:
- in whole or in part, by Medicaid, Medicare (including Medicare Part D), Tricare, Puerto Rico Government Health Insurance Plan, or any other federal or state-funded healthcare benefit program (collectively, "Government Programs"); and/or
- by commercial plans or other health or pharmacy benefit programs that reimburse for the entire cost of prescription drugs.
Eligible commercially insured and cash paying patients using this Card may pay as little as $20 for a 30-day prescription. Patient, pharmacist, and prescriber agree not to seek reimbursement for all or any part of the benefit received by the patient through the Card. Both patient and pharmacist are each individually responsible for reporting receipt of coupon benefit to any insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the Card, as required.
This Card is not health insurance and is not intended as a substitute for health insurance.
This Card can be used only by eligible residents in the United States and Puerto Rico and only at participating pharmacies. This offer is valid only for patients with a valid prescription for Niferex® tablets at the time the prescription is filled and dispensed by the pharmacist. Void where prohibited by law, taxed, or restricted.
The Card is limited to one per person and is not transferable. No substitutions are permitted. It is illegal to sell, purchase, trade, or counterfeit, or offer to sell, purchase, trade, or counterfeit the Card. The Card is available for each valid prescription. No other purchase is necessary. No income restrictions apply. This offer cannot be combined with any other rebate, coupon, free trial, discount, or similar offer.
Certain information pertaining to your use of the Card will be shared with Alora Pharmaceuticals, LLC, the sponsor of the Card, and its affiliates. The information disclosed may include the date the prescription is filled, the amount of product dispensed by the pharmacists, and the amount of your co-pay that will be paid for by using this Card. For more information, please see our Privacy Policy.
Alora Pharmaceuticals, LLC reserves the right to terminate, rescind, revoke, or modify the Card at any time without notice. Offer effective 12/2024. For expiration date, please refer to the Card.

Sumalate^® is a registered trademark of Albion Laboratories, Inc., covered by one or more claims of U.S. Patent Nos. 6,716,814, 8,007,846, and 8,425,956.

Quatrefolic^® is a registered trademark of Gnosis S.p.A., covered by one or more claims of U.S. Patent No. 7,947,662.

*This medication is best taken on an empty stomach 1 hour before or 2 hours after meals. If stomach upset occurs, the patient may take this medication with food. The patient should avoid taking antacids, dairy products, tea, or coffee within 2 hours before or after this medication because they will decrease its effectiveness.

REFERENCES: 1. Niferex^® Prescribing Information, Avion Pharmaceuticals, LLC, 2025. 2. Kamdi SP, Palkar PJ. Efficacy and safety of ferrous asparto glycinate in the management of iron deficiency anaemia in pregnant women. J Obstet Gynaecol. 2014; Early Online: 1–5. doi:10.3109/01443615.2014.930098. Accessed December 29, 2014. 3. Bovell-Benjamin AC, Viteri FE, and Allen LH. Iron absorption from ferrous bisglycinate and ferric trisglycinate in whole maize is regulated by iron status. Am J Clin Nutr. 2000; 71:1563–1569. 4. Edited by Allen, L, , de Benoist B, Dary O,Hurrel R. Guidelines on food fortification with micronutrients. World Health Organization and Food and Agricultural Organization of the United Nations.2006; 97-100. 5. Lynch SR, Cook JD. Interaction of vitamin C and iron (Abstract). Ann N Y Acad Sci. 1980; 355:32- 44. 6. NIH. Dietary Supplement Fact Sheet: Vitamin C. Updated: March 26, 2021. https://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/. 7. Brise H, Hallberg L. Effect of succinic acid on iron absorption. Acta Med Scand. 1962; 171(suppl 376):59-73. 8. Hallberg L, Norrby A, Solvell L. Oral iron with succinic acid in the treatment of iron deficiency anaemia. Scan J Haematol. 1971; 8:104-111. 9. Fischer J.A., Cherian Arlin M, Bone Jeffrey M , Karakochuk Crystal D. The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews, VR, Vol. 00 (0): 1-17. Published by Oxford University Press on behalf of the International Life Sciences Institute. 10. Lane JR, Bae DH, Merlot A, Sahni S, Richardson D. Duodenal Cytochrome b (DCYTB) in Iron Metabolism: An Update on Function and Regulation; Nutrients 2015, 7, 2274-2296. 11. Niferex-150 Forte 150 mg-25 mcg-1 mg capsule | Kaiser Permanente. 12. Pietrzik K Lynn Shane B, et al. Folic Acid and L-5-Methyltetrahydrofolate Comparison of Clinical Pharmacokinetics and Pharmacodynamics. Clin Pharmokinet. 2010: 49 (8): 636-5<18. 13. Herbig AK, Stover PJ. Regulation of folate metabolism by iron. In: Massaro EJ, Rogers JM. Folate and human development. Totowa, NJ: Humana Press 2002; 241-262. 14. NIH. Dietary Supplement Fact Sheet: B12. Updated: March 26, 2024. Website. https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/. 15. Wessels, I, Maywald M, Zinc as a Gatekeeper of Immune Function. Nutrients. 2017 Dec; 9(12): 1286; Published online 2017 Nov 25. doi: 10.3390 / nu9121286. NIH https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748737/

This content is for informational and educational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pediatrician, or other qualified healthcare provider with any questions you may have regarding diet and exercise during and after pregnancy, or other medical condition. For more information, please see our Terms of Use.

Important Safety Information, INCLUDING BOXED WARNING

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

DESCRIPTION: Niferex^® for oral administration is an iron supplement that is an oval, copper colored tablet with “344” embossed on one side.

OTHER INGREDIENTS: Dicalcium phosphate dihydrate, microcrystalline cellulose, croscarmellose sodium, stearic acid, silicon dioxide, magnesium stearate. Coating contains: Candurin® Orange (FD&C Blue #1, FD&C Red #40, FD&C Yellow #6), HPMC, titanium dioxide and triacetin. This product contains FD&C Yellow #6.

INDICATIONS: Niferex^® is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency.

CONTRAINDICATIONS: Niferex^® is contraindicated in patients with a known hypersensitivity to any of the ingredients.

PRECAUTIONS: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

ADVERSE REACTIONS: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

DOSAGE AND ADMINISTRATION: Usual dosage is one tablet daily with or without food or as prescribed by your healthcare provider.

HOW SUPPLIED: Bottles of 30 tablets (75854-344-30). The listed product number is not a National Drug Code. Instead, Avion Pharmaceuticals has assigned a product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and healthcare insurance computer systems.

STORAGE: Store at 20° - 25°C (68° - 77°F); excursions permitted to 15° - 30°C (59° - 86°F). [See USP Controlled Room Temperature.]

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

You may report side effects to Avion Pharmaceuticals, LLC at 1-888-612-8466 or to the FDA at 1-800-FDA-1088.

Please click here for full Prescribing Information, including Boxed Warning.